Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06917664 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

Name: Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease — clinical trial record (NCT06917664)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorChina National Center for Cardiovascular Diseases

Started2025-06-05

View on ClinicalTrials.gov ↗

Amendment history

2025-08-20

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2025-04→confirmed 2025-06-05

Study sitesdetails revised at 1 of 1 site

2025-04-02

Original filing

China National Center for Cardiovascular Diseases

127 trials monitored

See 4 trials at risk

Coronary Artery Disease

1,518 trials monitored

See 65 trials at risk

This study aims to evaluate the effect of angiotensin receptor/neprilysin inhibitors (ARNI) on improving ischemic mitral regurgitation (IMR) in patients with coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) through a randomized controlled clincial trial.

Trial Details

NCT Number	NCT06917664
Lead Sponsor	China National Center for Cardiovascular Diseases Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital, Chinese Academy of Medical Sciences
Conditions	Coronary Artery Disease, Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor
Enrollment	220 participants
Start Date	2025-06-05
Primary Completion	2026-12 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-27